Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Neuropharmacology
|
April 1, 1978
Modification of pentobarbital-induced sedation by natural and synthetic peptides
G Bissette, C B Nemeroff, P T Loosen, et al.
AJNR. American Journal of Neuroradiology
|
January 1, 1997
Hippocampal volume in normal aging and traumatic brain injury
E D Bigler, D D Blatter, C V Anderson, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE
|
January 6, 2009
Decisional conflict among patients who accept or decline participation in phase I oncology studies
Kathryn E Flynn, Kevin P Weinfurt, Damon M Seils, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1980
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity
T K Sawyer, P J Sanfilippo, V J Hruby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Impact of quality of life on patient expectations regarding phase I clinical trials
J D Cheng, J Hitt, B Koczwara, et al.
Breast Cancer Research and Treatment
|
June 27, 2003
Acceptability of diagnostic tests for breast cancer
Wenchi Liang, William F Lawrence, Caroline B Burnett, et al.
Pharmacology, Biochemistry, and Behavior
|
November 1, 1979
Neurotensin: distribution of hypothermic response in mammalian and submammalian vertebrates
A J Prange, C B Nemeroff, G Bissette, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2024
A frameshift mutation in the murine <i>Prkra</i> gene causes dystonia and exhibits abnormal cerebellar development and reduced eIF2α phosphorylation
Samuel B Burnett, Allison M Culver, Tricia A Simon, et al.
Disease Models & Mechanisms
|
November 8, 2024
Mutation in Prkra results in cerebellar abnormality and reduced eIF2α phosphorylation in a model of DYT-PRKRA
Samuel B Burnett, Allison M Culver, Tricia A Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction
Wenchi Liang, Caroline B Burnett, Julia H Rowland, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Neuropharmacology
|
April 1, 1978
Modification of pentobarbital-induced sedation by natural and synthetic peptides
G Bissette, C B Nemeroff, P T Loosen, et al.
AJNR. American Journal of Neuroradiology
|
January 1, 1997
Hippocampal volume in normal aging and traumatic brain injury
E D Bigler, D D Blatter, C V Anderson, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE
|
January 6, 2009
Decisional conflict among patients who accept or decline participation in phase I oncology studies
Kathryn E Flynn, Kevin P Weinfurt, Damon M Seils, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1980
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity
T K Sawyer, P J Sanfilippo, V J Hruby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Impact of quality of life on patient expectations regarding phase I clinical trials
J D Cheng, J Hitt, B Koczwara, et al.
Breast Cancer Research and Treatment
|
June 27, 2003
Acceptability of diagnostic tests for breast cancer
Wenchi Liang, William F Lawrence, Caroline B Burnett, et al.
Pharmacology, Biochemistry, and Behavior
|
November 1, 1979
Neurotensin: distribution of hypothermic response in mammalian and submammalian vertebrates
A J Prange, C B Nemeroff, G Bissette, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2024
A frameshift mutation in the murine <i>Prkra</i> gene causes dystonia and exhibits abnormal cerebellar development and reduced eIF2α phosphorylation
Samuel B Burnett, Allison M Culver, Tricia A Simon, et al.
Disease Models & Mechanisms
|
November 8, 2024
Mutation in Prkra results in cerebellar abnormality and reduced eIF2α phosphorylation in a model of DYT-PRKRA
Samuel B Burnett, Allison M Culver, Tricia A Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction
Wenchi Liang, Caroline B Burnett, Julia H Rowland, et al.
Page
of 11